How does a member use MARKABLE?

A member completes a seven-minute check from her own smartphone, at home. There is no lab visit and no referral or pre-authorisation. She receives a structured wellness summary she can follow over time and bring to a conversation with her own clinician.

For health plans & insurers

Support members through the transition, at population scale.

MARKABLE helps women notice and self-monitor perimenopause-related wellness patterns from their own phone, and prepare for conversations with their own clinician. It reaches women far from a clinic, with no lab visit and no referral or pre-authorisation. The health-equity story an insurer or employer can stand behind.

A general wellness product, not a medical device. Not a screening or diagnostic service.

Book a consultation → Learn more

Barriers MARKABLE removes

Lab visitNot required

Referral or pre-authorisationNot required

TransportationNot required

Time off workNot required

Smartphone-based. Scalable. Equitable.

Any phonereaches every
member, at home

0.87AUC, fused
multimodal model

2M+member Israeli
health fund

Patentpending, multimodal
platform

Why it matters

One of the largest underserved groups in women's health.

Most women pass through the perimenopause transition, and around three in four to four in five experience vasomotor symptoms during it. Around 3.5 million women of menopausal age are in work in the UK. Against that backdrop, MARKABLE offers a private, non-invasive way to reach these women where they already are, on the phone in their hand, through private insurers and employer wellbeing schemes.

~80%experience vasomotor
symptoms¹

3.5Mwomen of menopausal age
(45-54) in work in the UK²

~1 in 2who start hormone therapy
stop within the first year³

Any phonereaches every
member, at home

MARKABLE gives women a simple way to stay aware of their own wellness patterns and arrive at their own clinician conversations prepared.

MARKABLE is not an NHS service, is not commissioned by the NHS, and does not provide diagnosis or medical treatment.

How it works

Member engagement, at population scale.

MARKABLE runs on the phone women already carry, so it can be offered across a whole population, including women who live far from a clinic.

Women start from their own phone.

A selfie and a seven-minute check, at home, on any smartphone. There is no lab visit and no referral or pre-authorisation to complete first.

Five wellness signals, one picture.

Facial biomarkers, cognition, hearing, vision and symptoms are read together into one structured, longitudinal wellness summary the member can follow over time.

She arrives prepared for her own clinician.

The member brings a clear, structured wellness picture to the conversation she chooses to have, so the visit starts informed rather than from a blank page.

Reach that scales across the population.

Because it runs on a device women already own, MARKABLE can be offered to everyone, with no hardware to ship and no clinic appointment to book.

Health equity

A smartphone reaches members a clinic rarely does.

Monitoring a hormonal transition through the traditional path can mean a clinic appointment, a blood draw, a referral or pre-authorisation, transportation and time away from work. MARKABLE asks for a smartphone and about seven minutes, at home, on the woman's own schedule.

The women who are hardest to reach in a clinic are often the first a smartphone reaches at home. That is the equity story an insurer or employer can stand behind.

The platform

Five wellness signals, one member profile.

MARKABLE reads five wellness signals and fuses them into a single longitudinal wellness profile per member. Here is what each signal reads, and why it belongs in the picture.

Facial biomarkers

A single selfie reads a rich set of markers across the eye region, facial structure and volume, cutaneous texture, tone and the hairline, the morphological signals associated with the hormonal transition.

Facial

Cognition

Short on-phone games read processing speed, word retrieval, working memory and recall, the cognitive domains associated with hormonal change.

Cognitive

Hearing

Sound tasks read auditory processing, one of the sensory systems associated with the transition.

Sensory

Vision

Contrast and color tasks read visual processing, a second independent sensory signal.

Sensory

Symptoms

70+ symptom domains, captured structured, surface the patterns a woman rarely reports on her own.

Self-report

Research & validation

Built on real data, from real women.

In our pilot, the fused model reached an AUC of 0.87. It is early and observational, and we say so plainly. The current model fuses facial, symptom and cognitive signals across more than seventy symptom domains, and the research grows with every check. A paper is in preparation for peer review, and full validation detail is available on request.

0.87AUC, early
observational pilot

5independent wellness
signals fused

70+symptom
domains mapped

~7 mincheck, from
her own phone

Wellness-monitoring pilot in progress with a major Israeli health fund (2M+ members).

Clinical advisor Eran Gold, MD (OB/GYN) · AI & validation Shahar Fleishman, PhD

Member owns her data

Plan sees only aggregate, de-identified insights

Encrypted in transit & at rest

Designed for GDPR alignment

Patent Pending technology

General wellness product, not a medical device

Questions

Questions from health plan leaders

Is MARKABLE a medical device? +

No. MARKABLE is a general wellness product for personal awareness and self-monitoring, in line with FDA, MHRA (UK) and Israeli MOH general-wellness guidance. It is not a screening or diagnostic service and does not diagnose, treat, cure or prevent any disease.

Does MARKABLE reduce medical costs or claims? +

No. MARKABLE is a general wellness product and does not claim to reduce medical costs or claims. We report member engagement and self-reported wellness trends only, in quarterly aggregate summaries.

How do you measure success? +

Through engagement and awareness metrics: member enrollment, check completion, repeat use over time, and self-reported wellness trends across the cohort. All reporting to the plan is aggregate and de-identified.

Who owns the member data? +

The member owns her data. Health plans receive only aggregate, de-identified engagement and wellness insights. Individual-level data is not shared without the member's explicit consent, except as required by law.

How is MARKABLE priced for a plan? +

MARKABLE is typically offered on a per-member-per-month (PMPM) basis, scoped to plan size and engagement goals. Pilot-based pricing is also available. We can prepare a proposal for your member population on request.

How does this fit our systems? +

For a pilot, no integration is needed. Members access MARKABLE through a private web link. For a scaled deployment, integration pathways, including API and FHIR/HL7, can be scoped with your technical team.

Can we run a pilot? +

Yes. We offer structured pilots with a defined cohort, engagement metrics and timeline. A typical pilot runs with a few hundred members over three to six months, with a dedicated point of contact.

What clinical evidence exists? +

In our early observational pilot the fused model reached an AUC of 0.87. It is early, and we say so plainly. A paper is in preparation for peer review, and full methodology is available on request. Prospective validation studies are in planning.

Bring perimenopause wellness to your members.

Book a short consultation and we will walk you through how MARKABLE engages members and supports them through the transition, at population scale.

Book a consultation → Learn more

Here for yourself? Try a free personal check